Pricey Hepatitis C Drug Draws Criticism

To hear scientists talk about it, it’s nothing short of a wonder drug. The drug is sofosbuvir, called Solvadi by its manufacturer, and its effectiveness in treating hepatitis C is so pronounced that the U.S. regulators designated it “breakthrough therapy” when they approved it for U.S. markets last year. The catch is that it doesn’t come cheap: a single pill costs $1,000, meaning the 12-week daily dose prescribed for most patients will cost $84,000. That has brought howls of protests...

© La Voix de l'Amérique - samedi 26 juillet 2014